biostudies-literatureUnknown7(11)Alexander JLMedical Research CouncilNational Institute for Health Research (NIHR)Wellcome TrustCrohn's and Colitis UKThe lancet. Gastroenterology & hepatology1005-1015https://www.ebi.ac.uk/biostudies/studies/S-EPMC9458592biostudies-literatureCOVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.PMC9458592MR/W020610/1MR/W024977/1CL-2019-21-502MR/S019553/1MR/R02622X/1M14-5M2020-1 ParkesMR/S034919/1MC_PC_20060MR/M00533X/1220725/Z/20/ZMC_PC_19003MR/V036939/1NIHR300543Ramanathan AStark HSaifuddin AShah PKok KAhmad TBoyton RJSanchez JMendoza VMunoz Sandoval DGros Alcalde BPasquale CSebastian SHaq SRomanczuk LHart ALAlexander JLWilliams HRTKent AJReynolds CDomingo JChukwurah IPatel MCooke GRobisco-Diaz ECovil KWatkins DBalarajah SAnand NPatel KVGoodhand JRIbraheim HBewshea CBhatti SKourampa EBarnes AConstable LPollock KAnandabaskaran SHicks LCShamtally DCipriano BLee IVIP study investigatorsTeare JPLiu ZParkes MDerikx LKennedy NAGardner-Thorpe HLees CWIrving PMWilken-Smith SPowell NKing RBee LEstember CStone SKnight BLinger RCastro Seoane RFiorentino FBaden MD'Mello ARuocco GAltmann DMJones GRKirkwood JParkinson MNice RfalseCOVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.2022-01-01T00:00:00Z2022 Nov2026-05-28T04:21:35.347Z2024-11-15T17:30:08.454ZS-EPMC94585923608895410.1016/S2468-1253(22)00274-6